We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04167618
Brief Title: 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma

First Submitted : November 11, 2019
First Submitted that Met QC Criteria : November 14, 2019
First Posted : November 19, 2019

Last Update Submitted that Met QC Criteria : August 15, 2022
Last Update Posted : August 18, 2022